CLSI - NBS04
Newborn Screening by Tandem Mass Spectrometry
Organization: | CLSI |
Publication Date: | 1 May 2017 |
Status: | active |
Page Count: | 108 |
scope:
This guideline is intended to assist newborn screening (NBS) laboratory personnel in the routine use of tandem mass spectrometry (MS/MS) for the detection of metabolites that may indicate certain metabolic disorders using dried blood spot (DBS) specimens. The guideline describes:
• Preparation procedures for reagents, specimens, standards, and controls
• Calibration (both instrument and analyte)
• Standardization
• Control acceptance criteria
• Disorder profiles (interpretation of MS/MS spectra)
• External effects on results (eg, transfusion and total parenteral nutrition [TPN])
• Results reporting
• Second-tier testing
• Follow-up recommendations
This guideline:
• Is not intended to provide general information for screening on all conditions, only screening information related to MS/MS
• Does not cover confirmatory or diagnostic testing
Document History

